Key facts
- This page summarizes James E. Dentzer's Form 4 filing for CURIS INC (CRIS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 May 2024, 16:11.
James E. Dentzer - 21 May 2024 Form 4 Insider Report for CURIS INC (CRIS)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- CRIS
- Reported as of
- 21 May 2024
- Net transaction value
- +$1,162,000
- SEC form
- 4
- Accepted by SEC
- 23 May 2024, 16:11:48 UTC
- Prior SEC filing
- 18 Mar 2024
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Diantha Duvall, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James E. Dentzer filed Form 4 for CURIS INC (CRIS) on 23 May 2024.
Change
- Previous filing in this sequence was filed on 18 Mar 2024.
- Current net transaction value: +$1,162,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRIS
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $1,162,000
- Shares
- +100,000
- Change %
- Price
- $11.62
- Shares after
- 100,000
- Date
- 21 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $11.62
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 19, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to, among other things, increase the number of shares authorized for issuance thereunder and increase the per participant limit on the number of shares subject to awards that can be granted annually to participants in the plan; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.
Footnote F2
The option grant described in this Form 4 filing vests as to 25% of the original shares on January 19, 2025 and as to an additional 6.25% of the original shares each successive quarter and until January 19, 2028.